These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1068197)

  • 41. Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance.
    Roosenhoff R; van der Vries E; van der Linden A; van Amerongen G; Stittelaar KJ; Smits SL; Schutten M; Fouchier RAM
    PLoS One; 2018; 13(7):e0200849. PubMed ID: 30024940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
    J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amantadine-resistant influenza A virus in Taiwan.
    Shih SR; Lee CN; Tsai HR; Chen GW; Tsao KC
    J Formos Med Assoc; 2001 Sep; 100(9):608-12. PubMed ID: 11695276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).
    Mast EE; Harmon MW; Gravenstein S; Wu SP; Arden NH; Circo R; Tyszka G; Kendal AP; Davis JP
    Am J Epidemiol; 1991 Nov; 134(9):988-97. PubMed ID: 1951297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-influenza A activity of combinations of amantadine and ribavirin in ferret tracheal ciliated epithelium.
    Burlington DB; Meiklejohn G; Mostow SR
    J Antimicrob Chemother; 1983 Jan; 11(1):7-14. PubMed ID: 6826488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phylogenetic analysis of an off-seasonal influenza virus A (H3N2) in Niigata, Japan, 2010.
    Dapat C; Suzuki Y; Kon M; Tamura T; Saito R; Dapat IC; Yamazaki O; Odagiri T; Fujisaki S; Suzuki H
    Jpn J Infect Dis; 2011; 64(3):237-41. PubMed ID: 21617310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004/2005 to 2008/2009 winter seasons.
    Correia V; de Andrade HR; Santos LA; Lackenby A; Zambon M
    Antiviral Res; 2010 May; 86(2):128-36. PubMed ID: 20083142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular basis of resistance of influenza A viruses to amantadine.
    Hay AJ; Zambon MC; Wolstenholme AJ; Skehel JJ; Smith MH
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():19-29. PubMed ID: 3793659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunogenic properties of epidemic and recombinant strains of influenza viruses H1N1 and H3N2].
    Shchipanova MV; Podcherniaeva RIa; Blinova VK
    Vopr Virusol; 1984; 29(3):273-6. PubMed ID: 6464424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza infection of the embryonated hen's egg/an alternative model for in vivo evaluation of antiviral compounds.
    Härtl A; Sauerbrei A; Stelzner A; Wutzler P
    Arzneimittelforschung; 2004; 54(2):130-4. PubMed ID: 15038464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of amantadine-resistant influenza A virus isolated from 2001-02 to 2004-05 in Nara Prefecture.
    Kitahori Y; Nakano M; Inoue Y
    Jpn J Infect Dis; 2006 Jun; 59(3):197-9. PubMed ID: 16785705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
    Shen Z; Bowen RA; Ge P; Yu J; Shen Y; Kong W; Jiang C; Wu J; Zhu C; Xu Y; Wei W; Rudenko L; Kiseleva I; Xu F
    Vaccine; 2016 Nov; 34(48):5953-5958. PubMed ID: 27997342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Incidence of amantadine-resistant influenza A virus isolated in 1999/2000. Epidemic season in Shizuoka Prefecture].
    Sahara K; Sugieda M; Nagaoka H; Akiyama M; Uenoyama H; Nakajima S
    Kansenshogaku Zasshi; 2001 Jul; 75(7):576-7. PubMed ID: 11521282
    [No Abstract]   [Full Text] [Related]  

  • 55. Dual mutations in the HA1 peptide of amantadine-resistant influenza viruses at positions 193 and 225.
    Inoue Y; Yoneda M; Kitahori Y
    Jpn J Infect Dis; 2007 May; 60(2-3):147-8. PubMed ID: 17515655
    [No Abstract]   [Full Text] [Related]  

  • 56. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
    Takeda M; Pekosz A; Shuck K; Pinto LH; Lamb RA
    J Virol; 2002 Feb; 76(3):1391-9. PubMed ID: 11773413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective efficacy of a live, attenuated, influenza virus vaccine ('Alice' strain).
    Prinzie A; Delem A; Huygelen C
    Postgrad Med J; 1976 Jun; 52(608):395-8. PubMed ID: 785431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The selection of cold-adapted variants of the influenza viruses H1N1 and H3N2 and their antigenic and genetic characteristics].
    Podcherniaeva RIa; Döhner L; Medvedeva TE; Aleksandrova GI
    Vopr Virusol; 1991; 36(2):100-2. PubMed ID: 1882517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity of influenza A/New Jersey/8/76 (Hsw1N1) virus to amantadine-HCl.
    Grunert RR; Hoffmann CE
    J Infect Dis; 1977 Aug; 136(2):297-300. PubMed ID: 894080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amantadine resistance among highly pathogenic avian influenza viruses (H5N1) isolated from India.
    Jacob A; Sood R; Chanu KhV; Bhatia S; Khandia R; Pateriya AK; Nagarajan S; Dimri U; Kulkarni DD
    Microb Pathog; 2016 Feb; 91():35-40. PubMed ID: 26639679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.